Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.50
-0.09 (-0.94%)
At close: Nov 21, 2024, 4:00 PM
9.55
+0.05 (0.53%)
After-hours: Nov 21, 2024, 6:16 PM EST
Amicus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -104.69 | -151.58 | -236.57 | -250.46 | -276.85 | -356.39 | Upgrade
|
Depreciation & Amortization | 8.69 | 7.87 | 5.34 | 6.21 | 8.85 | 4.78 | Upgrade
|
Other Amortization | 2.2 | 2.62 | 2.63 | 2.49 | 1.79 | 2.55 | Upgrade
|
Asset Writedown & Restructuring Costs | 2.73 | 2.73 | 18.18 | - | 0.1 | - | Upgrade
|
Stock-Based Compensation | 83.78 | 86.08 | 76.51 | 57.84 | 49.15 | 44.43 | Upgrade
|
Other Operating Activities | 35.28 | 31.19 | 7.21 | 10.37 | 15.74 | 42.61 | Upgrade
|
Change in Accounts Receivable | -20.58 | -20.11 | -17.33 | -8.19 | -11.22 | -11.11 | Upgrade
|
Change in Inventory | -64.01 | -44.61 | -5.34 | -7.79 | -4.64 | -5.11 | Upgrade
|
Change in Accounts Payable | -3.39 | 49.2 | -6.38 | 7.43 | -10.61 | 46.74 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | - | -5.5 | Upgrade
|
Change in Other Net Operating Assets | 33.48 | -32.46 | -10.83 | -20.39 | -5.6 | -13.4 | Upgrade
|
Operating Cash Flow | -26.52 | -69.09 | -166.58 | -202.49 | -233.29 | -250.42 | Upgrade
|
Capital Expenditures | -5 | -7.44 | -3.77 | -3.88 | -3.23 | -20.01 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 3.41 | - | - | - | Upgrade
|
Investment in Securities | 0.87 | 105.5 | 92.67 | 82.65 | -10.35 | 115.17 | Upgrade
|
Investing Cash Flow | -4.13 | 98.06 | 92.32 | 78.76 | -13.58 | 95.15 | Upgrade
|
Long-Term Debt Issued | - | 387.36 | - | - | 385.93 | - | Upgrade
|
Long-Term Debt Repaid | - | -408.32 | -0.28 | -0.48 | -155.33 | -0.42 | Upgrade
|
Net Debt Issued (Repaid) | -20.93 | -20.96 | -0.28 | -0.48 | 230.6 | -0.42 | Upgrade
|
Issuance of Common Stock | 57.52 | 103.21 | 4.31 | 229.21 | 42.28 | 201.28 | Upgrade
|
Repurchase of Common Stock | -22.76 | -17.92 | -11.49 | -15.01 | -10.03 | -3.24 | Upgrade
|
Other Financing Activities | -1.59 | -2.65 | - | -1.65 | - | 19.88 | Upgrade
|
Financing Cash Flow | 12.23 | 61.68 | -7.46 | 212.07 | 262.86 | 217.5 | Upgrade
|
Foreign Exchange Rate Adjustments | -11.04 | 6.31 | -14.62 | -5.05 | 3.83 | 1.73 | Upgrade
|
Net Cash Flow | -29.45 | 96.96 | -96.34 | 83.29 | 19.82 | 63.97 | Upgrade
|
Free Cash Flow | -31.51 | -76.53 | -170.34 | -206.38 | -236.52 | -270.43 | Upgrade
|
Free Cash Flow Margin | -6.38% | -19.16% | -51.74% | -67.55% | -90.66% | -148.39% | Upgrade
|
Free Cash Flow Per Share | -0.10 | -0.26 | -0.59 | -0.76 | -0.91 | -1.12 | Upgrade
|
Cash Interest Paid | 48.23 | 36.09 | 34.36 | 30.47 | 24.68 | 16.97 | Upgrade
|
Cash Income Tax Paid | 4.78 | 8.53 | 1.61 | 20.03 | 10.37 | 0.69 | Upgrade
|
Levered Free Cash Flow | -10.72 | -25.89 | -94.23 | -84.97 | -137.55 | -152.91 | Upgrade
|
Unlevered Free Cash Flow | 18.62 | 2.84 | -73.66 | -67.16 | -125.32 | -143.66 | Upgrade
|
Change in Net Working Capital | 77.85 | 37.74 | 23.98 | 2.38 | 27.69 | -15.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.